How 4D Molecular Therapeutics, Inc. stacks up

FDMT · against 479 other Healthcare companies of similar size

Overall

43/ 100

Below the middle of the pack.

Ranked #284 of 480 · scores higher than 39% of peers

Bars: peers in each 10-point band of the overall score

91 peers with an overall score of 40–49, including FDMT · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#316 of 486Score 8 / 100 · beats 12%Growth#11 of 438Score 96 / 100 · beats 97%Profitability#430 of 482Score 11 / 100 · beats 10%Risk#244 of 491Moderate relative risk · safety 58 · beats 50%

Ranking by overall score

Top 5 and the companies ranked around FDMT

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	97	96	98	99	0 / 2
2	Zevra Therapeutics, Inc.ZVRA · US-listed	609M USD	91	95	99	99	0 / 2
3	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
4	Amoy Diagnostics Co., Ltd.300685.SZ · China	7.5B CNY (≈$1.1B)	82	72	64	96	0 / 2
5	CorMedix Inc.CRMD · US-listed	433M USD	81	96	99	99	2 / 2
⋯
284	Maccura Biotechnology Co.Ltd300463.SZ · China	5.5B CNY (≈$764M)	43	48	7	39	0 / 2
284	Tinavi Medical Technologies Co., Ltd.688277.SS · China	6.8B CNY (≈$959M)	43	0	89	23	1 / 2
284	American Oncology Network, Inc.AONC · US-listed	336M USD	43	0	86	76	2 / 2
284	Castle Biosciences, Inc.CSTL · US-listed	1.1B USD	43	8	57	31	0 / 2
284	4D Molecular Therapeutics, Inc.FDMT · US-listed	660M USD	43	8	96	11	1 / 2
284	Integra LifeSciences Holdings CorporationIART · US-listed	1.1B USD	43	60	42	42	2 / 2
292	C.Q. Pharmaceutical Holding Co., Ltd.000950.SZ · China	8.9B CNY (≈$1.2B)	42	59	52	41	2 / 2
292	Luyan Pharma Co.,Ltd.002788.SZ · China	3.7B CNY (≈$520M)	42	85	32	48	2 / 2
292	Wuhan Easy Diagnosis Biomedicine Co.,Ltd.002932.SZ · China	3.4B CNY (≈$469M)	42		3	27	0 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…